JOHANNA MATTHEWS: Open Payments
NPI 1851058549 · POST FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$529 in 24 payments from 8 companies in 2025. Trend: 2023 $1,247 · 2024 $407 · 2025 $529
Food & beverage: $529
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $279 |
| Supernus Pharmaceuticals, Inc. | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 3 | $51 |
| Janssen Pharmaceuticals, Inc | 2 | $34 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| Vanda Pharmaceuticals Inc. | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Alkermes, Inc. | 1 | $21 |
Products named: CAPLYTA, Qelbree, REXULTI, SPRAVATO, COBENFY, FANAPT, Auvelity, LYBALVI.
Industry payments across ID — which companies pay providers there.
